Paper Details

  1. Home
  2. Paper Details

Development of Randomized Trials in Adults with Medulloblastoma-The Example of EORTC 1634-BTG/NOA-23.

Author: AnazodoAntoinette, BeierDagmar, BerghoffAnna S, BrombergJacoline E C, CombsStephanie E, DirvenLinda, EffeneyRachel, FranceschiEnrico, FrappazDidier, GautierJulien, GorliaThierry, HattingenElke, HauPeter, HoferSilvia, HoveyElizabeth, KleinMartin, KortmannRolf-Dieter, McCabeMartin G, PajtlerKristian W, PeetersEllen, PfisterStefan M, PinedaEstela, PreusserMatthias, RutkowskiStefan, SahmFelix, SeidelClemens, SunyachMarie-Pierre, TanguyRonan, VanlanckerMaureen, WellerMichael, WickWolfgang, WiestlerBenedikt, ZieglerDavid S, ZimmerClaus, von DeimlingAndreas

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.

Overview

This study describes the EORTC 1634-BTG/NOA-23 trial, which will investigate the efficacy and safety of sonidegib (a smoothened inhibitor) in patients with medulloblastoma. The trial aims to improve treatment outcomes by reducing radiotherapy-related toxicity and increasing efficacy.
Paper Details　
Original Abstract of the Article :
Medulloblastoma is a rare brain malignancy. Patients after puberty are rare and bear an intermediate prognosis. Standard treatment consists of maximal resection plus radio-chemotherapy. Treatment toxicity is high and produces disabling long-term side effects. The sonic hedgehog (SHH) subgroup is hig...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8303185/

データ提供：米国国立医学図書館（NLM）

Randomized Trials for Medulloblastoma: Improving Treatment Outcomes

This study examines the challenges of treating medulloblastoma, a rare and aggressive brain tumor, in adults. The authors outline a new clinical trial (EORTC 1634-BTG/NOA-23) that aims to improve treatment outcomes by using a combination of standard therapies and novel targeted agents. It's like exploring a new desert path, seeking to find more effective treatments for this challenging disease.

Personalized Treatment: A Tailored Approach to Medulloblastoma

The study emphasizes the importance of personalized medicine in treating medulloblastoma, utilizing targeted therapies based on the specific molecular characteristics of the tumor. It's like customizing a camel caravan for a specific desert route, taking into account the unique terrain and challenges of the journey.

Hope for Medulloblastoma Patients

This research offers a beacon of hope for patients with medulloblastoma, showcasing the promise of clinical trials in improving treatment outcomes and minimizing the long-term effects of this disease. It's a reminder that even in the harshest deserts of medical challenges, there are new paths to explore and new oases of hope to discover.

Dr.Camel's Conclusion

This study underscores the importance of ongoing clinical research in developing more effective treatments for medulloblastoma. It's a reminder that even in the vast and challenging landscape of medical research, there are always new discoveries to be made and new opportunities to improve patient outcomes.
Date :
  1. Date Completed n.d.
  2. Date Revised 2021-07-29
Further Info :

Pubmed ID

34298664

DOI: Digital Object Identifier

PMC8303185

Related Literature

Article Analysis
・Side Effects of sonidegib
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.